DUBAI, Jan 25 (Reuters) - Saudi Arabia's Ministry of
Investment signed an agreement with GSK on Monday to
boost the kingdom's healthcare and life sciences sector, it said
on Twitter.
(Reporting by Yasmin Hussein; Writing by Lina Najem;
Editing by Louise Heavens)
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.
Read more